The facts
Quarterly diluted earnings were US$0.94 per share under GAAP and US$0.97 on Colgate's Base Business non-GAAP measure, compared with US$0.91 on each measure a year earlier. [1]
Reuters reported LSEG analyst averages of US$5.33 billion in sales and US$0.93 in adjusted earnings per share. The adjusted US$0.97 result is compared with the adjusted estimate, not GAAP earnings. [2]
Organic sales rose 3.6%, including a 0.2 percentage-point negative effect from lower private-label pet-food sales, the company said. [1]
The company narrowed its forecast for 2026 net-sales growth to 4–5% from 2–6%. Its revised full-year forecasts are expectations, not achieved annual results. [1][2]
Sources
References support the numbered facts above. Source checks: 30 Oct 2026, 14:43 UTC.
- Colgate-Palmolive announces 3rd quarter 2026 results
Colgate-Palmolive / Business Wire, via Nasdaq · Primary source · 30 Oct 2026
Actual issuer release read, including quarterly GAAP/non-GAAP comparisons and previous/revised full-year guidance. The branded organic and Base Business measures are not treated as GAAP.
- Colgate-Palmolive en hausse après avoir revu à la hausse ses prévisions de bénéfice annuel
Reuters, via Boursorama · Reporting · 30 Oct 2026
Actual Reuters French report read; labelled automated translation. Independent of Colgate and Business Wire. Its named LSEG benchmarks are kept separate from Bloomberg estimates in other coverage. A narrower sales range is not described as a cut to both bounds.